Expert NetworkExpert InterviewMAZE

Slingshot members are talking to an expert! The topic is:

Reviewing Maze Therapeutics' Topline Data from the Phase 2 HORIZON Trial of MZE829 in Patients with Broad APOL1-Mediated Kidney Disease

Executed on:Apr 13, 2026 2:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Iowa
  • Clinical Professor of Internal Medicine - Nephrology, and Medical Director for dialysis at University of Iowa
  • Currently manages 30+ patients with focal segmental glomerulosclerosis and 200 patients for potassium management
  • Research interests in IgA neuropathy, renal transplantation outcomes, and kidney dialysis

Interview Goal

The goal of this interview with a nephrologist is to discuss the Phase 2 HORIZON trial of MZE829 in APOL1-mediated kidney disease and its potential fit within the current treatment landscape. 

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.